Clinical trial
To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With…
NCT00053560 · Genelabs Technologies, Industry · Unknown status
Key facts
| NCT number | NCT00053560 |
|---|---|
| Title | To Assess Prevention of Bone Loss in Women With Lupus Receiving Treatment With Glucocorticoids |
| Official title | A Randomized, Double-Blind, Multi-Center, Placebo- Controlled Study to Assess Prevention of Bone Loss by Treatment With GL701 (Prestara) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids |
| Lead sponsor | Genelabs Technologies, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lupus |
| Intervention type | Drug |
| Interventions | Prasterone (GL701) |
| Enrollment | 155 |
| Start date | Dec 1, 2002 |
| Completion | Aug 1, 2004 |
| First posted | Feb 3, 2003 |
| Last update posted | Jan 7, 2008 |
| Countries | Mexico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: